The small subunit of the Bacillus subtilis bacteriophage SPP1 terminase (G1P) forms a sequencespecific nucleoprotein complex with the SPP1 non-encapsidated end (pacL site) during initiation of DNA encapsidation. Gel mobility shift assay was used to study the G1P-pacL interaction. Distamycin, a minor groove binder that induces local distortion of the DNA, inhibits G1P-pacL complex formation. The competition of G1P with distamycin for DNA binding at the pacL site is independent of the order of addition of the reactants. Other minor groove binders, such as spermine or Hoechst 33258, which do not distort DNA, failed to compete with G1P for pacL DNA binding. Cationic metals, which generate a repertoire of DNA structures different from that caused by the minor groove binders, can partially reverse the distamycininduced inhibition of G1P binding to pacL DNA. The major groove binder methyl green, which does not distort sequence-directed bending of pacL DNA, competes with G1P for binding at the pacL site. Our data suggest that the natural sequence-directed bend that exists within the pacL site is the architectural element that facilitates assembly of a nucleoprotein complex and hence initiation of DNA encapsidation by bacteriophage SPP1.
INTRODUCTION
Initiation of packaging of double-stranded viral DNA concatemers involves specific interaction of the prohead with virus DNA in a process mediated by a phage-encoded DNA recognition and cleavage (terminase) protein (reviewed in 1,2). The terminase enzymes described so far, which are hetero-oligomers composed of a small and a large subunit, do not have a significant level of sequence homology (reviewed in 1). The role of the terminase small subunit is to specifically recognize the packaging initiation site (cos or pac). It is thought that the small terminase subunit forms a nucleoprotein structure that helps to position the terminase large subunit at cos or pac (reviewed in 1).
The Bacillus subtilis bacteriophage SPP1 terminase enzyme is composed of a small (G1P) and a large (G2P) subunit which are the products of genes 1 and 2 respectively (3). G1P (estimated native molecular mass 190-210 kDa) is a three-domain protein (DNA binding and G1P-G1P and G1P-G2P interacting domains) (4, 5) . The N-terminal domain contacts DNA by a helix-turn-helix (HTH) motif, the central domain mediates the G1P-G1P contact, whereas an uncharacterized domain could mediate G1P-G2P hetero-oligomer formation. No apparent biological role can be assigned to the C-terminal region (5) .
The SPP1 pac region can be subdivided into three discrete sites (pacL, pacC and pacR). The G2P cleavage site (pacC) is located between the pacL and pacR sites (3-7; Fig. 1 ). G1P binds co-operatively to the encapsidated (pacR) and non-encapsidated (pacL) DNA ends and holds the two binding sites together in a DNA loop (4) . DNase I footprinting experiments indicate that each G1P binding site contains two discrete binding domains, termed box a in pacL and box c in pacR (4; see Fig. 1 ). The pacL and pacR sites are separated from each other by a stretch of 140 bp (4) . The center-to-center distance of these two non-adjacent sites is ∼204 bp (4; Fig. 1 ). The G1P recognition site at pacL is embedded in a sequence-directed DNA bend. The interaction of G1P with pacL DNA is observed only on one side of the double helix (4) . The pacL site contains two directly repeated boxes (box a), which are located four helical turns away from each other (Fig. 1) . G1P binding to pacL enhances DNA bending. Therefore, any interaction between G1P bound to pacL and G1P bound to pacR would give rise to a loop of 204 bp in length (or ∼20 turns of the DNA helix) (4). DNA loop formation mediated by G1P could distort the DNA within the loop and hence alter the binding characteristics of G2P to its asymmetric target site (4). Additional evidence for DNA looping is provided by alternating DNase I-hypersensitive and DNase I-resistant sites in the complexed DNA, which appear with an approximate periodicity of 10 bp (see Fig. 1 ). To address the nature of the interaction between G1P and the pacL site and to elucidate the influence of intrinsic DNA bending on this reaction several groove binders (GBs) were employed. The pyrrole amide antibiotic distamycin A (henceforth distamycin) binds to the minor groove of B-DNA in a non-covalent and a non-intercalative mode (8) . Distamycin associates preferentially with a nucleotide sequence rich in adenosine (A) and thymine (T) base pairs. Distamycin binds to the minor groove of B-DNA and induces local structural distortion by bending the DNA helix and inducing conformational changes in the neighborhood (9,10). Electron microscopic (11), 1 H-NMR (12) and X-ray crystallographic (13) studies provide direct evidence of distamycin-induced changes of local DNA structures. Distamycin interferes with proteins that act upon DNA binding (14) (15) (16) . The binding of distamycin to the minor groove of DNA can compete with protein binding. Alternatively, the binding of distamycin in the minor groove induces a change in the local conformation which diminishes binding affinity of the protein for the major groove.
In this paper we present evidence that binding of G1P to the intrinsically bent locus within pacL is inhibited by the minor GB distamycin and the major GB methyl green. Distamycin competition for G1P binding to the pacL DNA segment is independent of the order of addition of the reactants. Other minor GBs that do not distort DNA upon binding (spermine and Hoechst 33258) do not compete with G1P for pacL binding. Cationic metals, which generate a different repertoire of DNA structures, can partially reverse the distamycin-induced inhibition of G1P binding to pacL DNA. It is likely, therefore, that the distamycin-induced conformational change diminishes the binding affinity of G1P for pacL DNA (the SPP1 non-encapsidated end).
MATERIALS AND METHODS

Bacterial strains and plasmids
Escherichia coli strain JM109 (17) and plasmid pBT397 (5) have been previously described.
Enzymes and reagents
SPP1 G1P was purified as previously described (5) . Protein concentrations were determined by the method of Bradford (18) , using bovine γ-globulin as a standard. The amount of G1P is expressed as mol protein protomers (predicted molecular mass of SPP1 G1P is 20.7 kDa). DNA restriction and modification enzymes and poly(dI-dC) were purchased from Boehringer Mannheim (Germany), distamycin and spermine from Sigma (USA), Hoechst 33258 from Polysciences Inc. (USA) and methyl green from ICN (Germany). All chemicals used were reagent grade and solutions were made in quartz-distilled H 2 O.
[α-32 P]dATP was from Amersham Buchler GmbH (Germany). Ultra pure acrylamide was from Serva (Germany).
DNA manipulations
Covalently closed circular plasmid DNA was purified by the SDS lysis method (19) , followed by purification on a cesium chloride-ethidium bromide gradient. Gel-purified DNA fragments were end-labeled by filling in the restriction site with the large fragment of DNA polymerase I in the presence of [α-32 P]dATP and dTTP, dCTP and dGTP.
Analytical and preparative gel electrophoresis of plasmid DNA and restriction fragments was carried out either in 0.8% (w/v) agarose, Tris-acetate-EDTA, ethidium bromide horizontal slab gels or 4% (w/v) non-denaturing polyacrylamide, Tris-borate gels (19) .
The relative amounts of DNA present in any particular band in the autoradiograms was quantitatively scanned with a laser densitometer (LKB UltroScan XL). The linearity of the response with respect to DNA concentration was checked using autoradiograms at different exposure times. Quantitative scans were integrated using the LKB GelScan XL software package.
The concentration of the 324 bp pacL DNA was determined using molar extinction coefficients of 6500/M/cm at 260 nm. Except for poly(dI-dC), the amount of DNA is expressed as mol DNA molecules.
Gel shift assay
The SPP1 271 bp HpaII-BsmI SPP1 pacL DNA fragment (obtained as a 324 bp segment) was labeled with [α-32 P]dATP by filling in the ends (EcoRI-HindIII) with the large fragment (Klenow) of DNA polymerase I. The unincorporated nucleotides were removed by gel filtration.
In all conditions 23 pM α-32 P-labeled DNA (324 bp pacL DNA) and 1 µg poly(dI-dC) were used per reaction mixture (20 µl). When required the pacL DNA was incubated with an excess of G1P (240 nM) for 10 min at 37_C. When indicated increasing concentrations of a GB or metal cations were added prior to or after G1P-pacL complex formation. The binding reactions were immediately subjected to 4% non-denaturing polyacrylamide gel electrophoresis (ndPAGE) and run at 2 V/cm at 4_C. The gels were dried prior to autoradiography.
RESULTS
G1P binding to the pacL DNA is inhibited by distamycin
Recently it has been shown that: (i) the SPP1 terminase small subunit (G1P) binds specifically and co-operatively to pacL (non-encapsidated end) and pacR (encapsidated end) sites; (ii) the pacL site contains an intrinsically bent sequence; (iii) G1P binding to the pac region enhances DNA looping between the pacL and pacR sites (4). To address whether the intrinsically bent pacL sequence plays a role in G1P-pacL interaction we have analyzed the influence of distamycin on G1P binding by gel shift assay. It has been reported that at low doses (500 nM-1 µM) distamycin selectively prevents DNA bending and does not abolish protein-DNA interactions, whereas high doses (1-200 µM) induce local structural distortions by bending the DNA helix (9, 10) .
In a previous study we showed that G1P-pac DNA complexes remain in the well when a low ionic strength ndPAGE running buffer is used in the gel shift assay, whereas in high ionic strength ndPAGE a diffuse retarded G1P-pac DNA complex is observed (5) . Under high ionic strength ndPAGE conditions, however, an ∼15-fold excess of G1P is required to saturate the DNA substrate when compared with the G1P-pac DNA complexes retained by the filter binding assay (see 4). Since a high ionic strength ndPAGE running buffer was used, we first set up the conditions of the gel shift assay to maximize complex formation using a fixed amount of labeled DNA fragment (23 pM) and purified G1P (240 nM).
The SPP1 324 bp [ 32 P]pacL DNA, which is rich in dA + dT, migrates much slower than a 430 bp size marker DNA fragment in 4% ndPAGE at 4_C (4; Fig. 2A ). This anomalous mobility is greatly reduced at higher temperatures, implying the existence of sequence-directed curvature (see 4) .
To examine the influence of distamycin on the conformation of pacL DNA we incubated the 324 bp [ 32 P]pacL DNA (23 pM) and 1 µg poly(dI-dC) with varying concentrations of distamycin (1 nM-100 µM) and subjected the reaction mixture to ndPAGE. As revealed in Figure 2A , distamycin influences the mobility of pacL DNA. Distamycin concentrations from 1 nM to 1 µM increase the mobility of the pacL DNA fragment. In the presence of 1 µM distamycin the 324 bp [ 32 P]pacL DNA segment migrated between the 341 and 380 bp size markers ('reduced curvature'), but in the presence of higher concentrations of distamycin (5-100 µM) the DNA fragment again migrated slower than the 430 bp size marker DNA fragment ( Fig. 2A) .
In the presence of 100 nM distamycin (∼13 distamycin molecules/bp pacL DNA) migration of the fragment was faster than in its absence, but to obtain the fastest migrating DNA segment 1 µM distamycin (134 distamycin molecules/bp pacL DNA) was needed. The absence of a large excess of non-specific competitor DNA [1 µg poly(dI-dC)] did not alter the pattern observed in Figure 2A (data not shown). It is likely, therefore, that poly(dI-dC) does not titrate distamycin for pacL DNA.
Pre-incubation of distamycin with the 324 bp [ 32 P]pacL DNA fragment (23 pM) reduced the ability of G1P (240 nM) to bind to its target DNA in a concentration-dependent manner (Fig. 2B) . Inhibition of G1P binding to pacL DNA occurred at the same distamycin concentrations that modified or eliminated curvature of the naked DNA ( Fig. 2A and B) .
As revealed in Figure 2B , G1P-pacL DNA complex formation was completely blocked at 1 µM distamycin, while the first indication of inhibition of complex formation was seen at 500 nM distamycin. The amount of distamycin required to prevent 50% G1P-pacL DNA complex formation was ∼750 nM. The distamycin-induced inhibition of G1P-pacL DNA complex formation is independent of the order of addition of the reactants. The same results were obtained when the pacL DNA was pre-incubated with distamycin and G1P was added subsequently as when the G1P-DNA complex was pre-formed and then challenged with distamycin (data not shown).
It could be hypothesized that distamycin inhibits G1P-pacL complex formation either by competing for binding to the minor groove of DNA or by altering the local DNA conformation of pacL DNA, which could diminish the binding affinity of G1P for DNA. These two possibilities were therefore analyzed.
The minor groove binders spermine and Hoechst 33258 do not compete with G1P for binding to pacL DNA
To analyze whether distamycin-induced inhibition of G1P binding to pacL DNA is due to an occupancy of the same site we used minor GBs that do not modify the structure of DNA upon binding, such as spermine (20) or Hoechst 33258 (21) .
The presence of increasing concentrations of spermine (100 nM-1 mM) or Hoechst 33258 (100 nM-10 µM) did not alter the migration of DNA in 4% ndPAGE at 4_C (Fig. 3A and data  not shown) . The presence of concentrations of Hoechst 33258 >10 µM produced cross-linked or precipitated material and the DNA did not enter the gel.
Pre-incubation of pacL DNA (23 pM) and 1 µg poly(dI-dC) with increasing concentrations of spermine (100 nM-1 mM; Fig.  3B ) or of Hoechst 33258 (100 nM-10 µM; data not shown) and subsequent addition of G1P (240 nM) did not affect the affinity of G1P for pacL DNA under our experimental conditions. The same effect was observed when pre-formed complexes of G1P-pacL DNA were challenged with increasing concentrations of spermine or Hoechst 33258 (data not shown). The presence of a large excess (up to 4 × 10 3 molecules) of spermine per G1P molecule did not affect its binding to pacL DNA. It seems, therefore, that the minor GBs spermine and Hoechst 33258 do not compete with G1P for binding to pacL DNA.
Cationic metals partially compete with G1P binding to pacL DNA
Certain divalent cationic metals, such as Ba 2+ , Co 2+ , Mn 2+ and Zn 2+ , can promote sequence-directed DNA bending (22) . The fraction of molecules with a cation-induced bend is dependent on both the type and the concentration of cationic metal. MnCl 2 and BaCl 2 are most effective in inducing curvature at 50-100 mM and less effective at higher concentrations (22) . To analyze whether cationic metals could affect G1P binding to pacL DNA by generating a different repertoire of bent structures we have used BaCl 2 and MnCl 2 (see 22) .
As revealed in Figure 4 , the addition of 40-160 mM BaCl 2 or MnCl 2 reduced the mobility of the intrinsically bent 324 bp [ 32 P]pacL (23 pM) DNA segment in 4% ndPAGE at 4_C, implying that curvature is increased in the presence of the divalent cations. In the presence of 160 mM BaCl 2 <3% of total DNA showed an anomalous mobility, but at the same concentration of MnCl 2 >99% of the molecules showed an anomalous mobility when compared with absence of the cationic metals (see Fig. 4 ).
Pre-incubation of pacL DNA (23 pM) and 1 µg poly(dI-dC) with increasing concentrations (5-40 mM) of BaCl 2 (Fig. 4A) or MnCl 2 (Fig. 4B ) and subsequent addition of G1P (240 nM) did not affect the affinity of G1P for pacL DNA. It is likely, therefore, that the metal ions at concentrations ranging between 5 and 40 mM do not have a direct effect on G1P or on G1P interaction with DNA. In the presence of 80 or 160 mM MnCl 2 , however, ∼5% of total DNA were freed from the G1P-pacL complex (Fig.  4B) . Similar results were observed when other cationic metals (e.g. MgCl 2 ) that induce sequence-directed DNA bending were used (data not shown). It is likely, therefore, that metal ion-induced bending (see Fig. 4A ) can generate a DNA structure at pacL that is not recognized by G1P.
BaCl 2 reverses the distamycin-induced inhibition of G1P-DNA interaction
To examine whether distamycin-induced inhibition of G1P-pacL complex formation is due to a conformational change in the DNA we pre-incubated the 324 bp pacL DNA with distamycin and with increasing concentrations of BaCl 2 or MnCl 2 prior to addition of G1P. Figure 5A shows 324 bp [ 32 P]pacL DNA (23 pM) which was first incubated with 5 µM distamycin and then with increasing concentrations of BaCl 2. The latter reactant caused little effect, if any, on mobility of the DNA fragment in concentrations ranging from 5 to 20 mM. The presence of 40-160 mM BaCl 2 changed the mobility of 324 bp [ 32 P]pacL DNA (see Fig. 4A ) and addition of distamycin enhanced such an effect (see Fig. 5A ).
When the DNA was pre-incubated with 5 µM distamycin G1P was unable to form a complex with the 324 bp [ 32 P]pacL DNA (see Fig. 2B ), whereas when the DNA was pre-incubated with 5 µM distamycin and 5-40 mM BaCl 2 , G1P (240 nM) recovered its ability to bind the pacL DNA segment (Fig. 5B) . The presence of BaCl 2 (20-40 mM) reversed the negative effect of distamycin on G1P-DNA complex formation and >70% of the DNA was complexed with G1P ( Fig. 5B) . At higher concentrations of BaCl 2 (80 mM) we did not observe reversal of distamycininduced inhibition of the G1P-DNA interaction (Fig. 5B) . Similar results were observed when MnCl 2 was used (data not shown). These results indicate that these metal ions at concentrations ranging between 5 and 40 mM enhance a specific structure(s) ('active curvature') on the DNA that reverses distamycin-induced inhibition of the G1P-DNA interaction, whereas other repertoires of structures fail to reverse the negative effect of distamycin on G1P binding to pacL DNA.
Methyl green partially competes with G1P for binding to pacL DNA
In a previous study we showed that G1P lacking the DNA binding HTH motif (G1P*) is able to interact with wild-type G1P, but fails to bind to the SPP1 pac region (5). It is thought that the HTH motif is the principal structural element of the terminase small subunit of many different phages (reviewed in 1). To investigate whether G1P-pacL interaction also occurs in the major groove of DNA we measured G1P-DNA complex formation in the presence of increasing concentrations of methyl green, which is a major GB (see 23) .
As revealed in Figure 6A , the addition of 50 nM-50 µM methyl green did not modify mobility of the intrinsically bent SPP1 324 bp [ 32 P]pacL (23 pM) DNA segment in 4% ndPAGE at 4_C.
Methyl green concentrations ranging from 50 nM to 1 µM did not alter the rate of G1P-DNA complex formation, but at 50 µM it decreased the DNA binding activity of G1P to pacL DNA (Fig.  6B) . The amount of methyl green required to prevent 50% G1P-pacL DNA complex formation, compared with an untreated control, is <50 µM. Similar results were obtained when the pacL DNA was pre-incubated with methyl green and G1P was subsequently added (Fig. 6C; our unpublished results) .
DISCUSSION
Genetic evidence suggests that the terminase enzyme from the B.subtilis phage SPP1 is essential for recognition and cleavage at the packaging initiation region (pac) (3) . The terminase enzyme is a hetero-oligomer composed of a small (G1P) and a large (G2P) subunit, which are the products of genes 1 and 2 respectively. The pac region consists of three discrete sites (pacL, pacC and pacR) (4) . The site of double-stranded DNA cleavage by G2P is called pacC (4, 6, 7) , whereas the sites recognized by G1P in the encapsidated and non-encapsidated DNA strand are termed pacR (right) and pacL (left) respectively (4) .
In previous studies we have shown that G1P is an oligomer (190-210 kDa) with a ring-like structure in solution. We have shown that several G1P molecules specifically interact with an intrinsically bent region of pacL covering a tract of almost 100 bp and that the specific interaction between G1P and pacL occurs on only one side of the DNA double helix (4) . Upon binding to pac DNA G1P induces DNA bending and looping between the pacL and pacR sites and binding of G1P to pacL and pacR DNA facilitates assembly of a higher order nucleoprotein structure (4, 5) . On the basis of these data we have hypothesized that the G1P-pacL nucleoprotein complex and the G1P-pacR complex, with subsequent looping of the intervening DNA, could direct the positioning of G2P and define the directionality of DNA packaging (4) .
The small subunit of the terminase enzyme from different bacteriophages interacts with DNA through a HTH DNA binding motif (1) . In a previous study we postulated that G1P binding to the pac sites occurs in the major groove of B-DNA (3, 5) . In this study we show that methyl green, which is a major GB, affects the binding of G1P to pacL DNA. It is likely, therefore, that G1P interacts with DNA in the major groove.
The DNA features recognized by G1P indicate that the protein requires a bent DNA with an 'active' phase for assembly of a specialized nucleoprotein structure. Our studies have demonstrated that distamycin alters the mobility of pacL and interferes with G1P DNA binding. In the presence of 1 µM distamycin G1P fails to bind to the 'unbent' pacL DNA (Fig. 2B) . Distamycin concentrations ranging from 5 to 100 µM, which decreased the mobility of pacL DNA, inhibit binding of G1P to ('distamycininduced inactive bent') pacL DNA (Fig. 2B) . Inhibition of G1P binding is also observed after addition of distamycin to preformed G1P-pacL DNA complexes, suggesting that either binding of the antibiotic to the minor groove can displace G1P from the DNA or that upon binding of distamycin in the minor groove it induces a conformational change in DNA which diminishes the binding affinity of G1P for pacL DNA. The competition of distamycin for G1P binding to pacL is neither the result of inhibition of contacts of G1P with the minor groove nor a direct interaction of distamycin and G1P that interferes with binding of the protein to pacL. These conclusions are based, first, on the findings that other minor GBs that do not affect the mobility of pacL DNA in ndPAGE do not affect G1P-pacL complex formation and, second, that metal ions, which are agents known to promote DNA bending, can partially reverse distamycin-induced inhibition.
Previous studies have demonstrated that distamycin interferes with the interaction of proteins that bind to the DNA major groove at concentrations comparable (1-2 µM) with those required to interfere with protein-DNA complex formation (24, this work) or greater (20-200 µM) (15) . The interference caused by distamycin with proteins that interact with DNA through the major groove could be a result of a DNA conformation change, rather than a direct impediment due to occupancy by the minor GB of the protein target site. It is likely, therefore, that distamycin can effectively displace G1P bound in the major groove of DNA.
We show here that the specificity of G1P-pacL DNA binding is due not only to the sequence of its target site (box a), but also to the local conformation at that site. This conclusion is based on the finding that BaCl 2 and MnCl 2 , which are agents known to promote DNA bending (22) , can partially reverse (>70% of distamycin-induced inhibition at metal ion concentrations ranging from 20 to 40 mM) the inhibitory effect of distamycin. Higher concentrations of BaCl 2 or MnCl 2 , which promote DNA looping, also exerted a negative effect on G1P-pacL complex formation. It is likely that only a limited repertoire of DNA structures promoted by the metal ions could reverse distamycin-induced inhibition of G1P-pacL complex formation.
The specific interaction of G1P with pacL occurs on only one face of the DNA double helix (4). It is likely that G1P deflects the pacL DNA towards itself upon binding and the net curvature of pacL reaches extremes when the deformation affects the same DNA face ('active bend') or opposite DNA faces ('inactive bend'). Distamycin could affect both DNA faces or the opposite DNA face, generating a different trajectory of the DNA path. It is likely, therefore, that distamycin inhibits G1P-pacL complex formation by altering the conformation of pacL DNA, rather than by competing for binding to the minor groove (see 9, 16) .
In summary, G1P seems to interact with pacL DNA via the major groove. Upon binding of G1P to box a, which is embedded in the intrinsically bent pacL DNA, ∼100 bp are wrapped around a multimeric G1P molecule (4) . Distamycin, which is a drug that has been shown to remove DNA curvature (9), inhibits G1P-pacL complex formation. DNA curvature, which is particularly pronounced in the presence of divalent cations, reverses distamycin-induced inhibition of G1P-pacL complex formation.
